Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

2.

[Molecular mechanism of fatty acids impact on plasma lipid profile (part II)].

Swierczyński J, Chmielewski M, Wołyniec W, Rutkowski B.

Przegl Lek. 2007;64(1):42-7. Review. Polish.

PMID:
18183831
3.

Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.

Aleshin S, Strokin M, Sergeeva M, Reiser G.

Neurochem Int. 2013 Oct;63(4):322-30. doi: 10.1016/j.neuint.2013.06.012. Epub 2013 Jun 25. Review.

PMID:
23811400
4.

International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.

Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, Palmer CN, Plutzky J, Reddy JK, Spiegelman BM, Staels B, Wahli W.

Pharmacol Rev. 2006 Dec;58(4):726-41. Review.

5.
6.

Peroxisome proliferator-activated receptor agonists in a battle against the aging kidney.

Speeckaert MM, Vanfraechem C, Speeckaert R, Delanghe JR.

Ageing Res Rev. 2014 Mar;14:1-18. doi: 10.1016/j.arr.2014.01.006. Epub 2014 Feb 3. Review.

PMID:
24503003
7.

Peroxisome proliferator-activated receptors and their relevance to dermatology.

Friedmann PS, Cooper HL, Healy E.

Acta Derm Venereol. 2005;85(3):194-202. Review.

8.

Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins.

Schachtrup C, Emmler T, Bleck B, Sandqvist A, Spener F.

Biochem J. 2004 Aug 15;382(Pt 1):239-45.

9.

Lipolytic PPAR activation: new insights into the intersection of triglycerides and inflammation?

Ziouzenkova O, Plutzky J.

Curr Opin Clin Nutr Metab Care. 2004 Jul;7(4):369-75. Review.

PMID:
15192437
10.

[Role of the fatty acids in ovarian functions: involvement of peroxisome proliferator-activated receptors (PPAR) and adipokines].

Dupont J, Froment P, Ramé C, Pierre P, Coyral-Castel S, Chabrolle C.

Gynecol Obstet Fertil. 2008 Dec;36(12):1230-8. doi: 10.1016/j.gyobfe.2008.09.012. Epub 2008 Nov 13. Review. French.

PMID:
19013096
11.

Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.

Giaginis C, Tsantili-Kakoulidou A, Theocharis S.

Fundam Clin Pharmacol. 2007 Jun;21(3):231-44. Review.

PMID:
17521292
12.

N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity?

Delarue J, LeFoll C, Corporeau C, Lucas D.

Reprod Nutr Dev. 2004 May-Jun;44(3):289-99. Review.

PMID:
15460168
14.

Regulation of the peroxisomal beta-oxidation-dependent pathway by peroxisome proliferator-activated receptor alpha and kinases.

Latruffe N, Cherkaoui Malki M, Nicolas-Frances V, Clemencet MC, Jannin B, Berlot JP.

Biochem Pharmacol. 2000 Oct 15;60(8):1027-32. Review.

PMID:
11007938
15.

Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.

Oikari S, Ahtialansaari T, Huotari A, Kiehne K, Fölsch UR, Wolffram S, Jänne J, Alhonen L, Herzig KH.

Acta Physiol (Oxf). 2008 Sep;194(1):57-65. doi: 10.1111/j.1748-1716.2008.01860.x. Epub 2008 Apr 3.

PMID:
18394026
16.

Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.

Hsu WH, Chen TH, Lee BH, Hsu YW, Pan TM.

Food Chem Toxicol. 2014 Feb;64:94-103. doi: 10.1016/j.fct.2013.11.015. Epub 2013 Nov 22.

PMID:
24275089
17.

Rosiglitazone induction of Insig-1 in white adipose tissue reveals a novel interplay of peroxisome proliferator-activated receptor gamma and sterol regulatory element-binding protein in the regulation of adipogenesis.

Kast-Woelbern HR, Dana SL, Cesario RM, Sun L, de Grandpre LY, Brooks ME, Osburn DL, Reifel-Miller A, Klausing K, Leibowitz MD.

J Biol Chem. 2004 Jun 4;279(23):23908-15. Epub 2004 Apr 8.

18.
19.

Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling.

Gardner OS, Dewar BJ, Graves LM.

Mol Pharmacol. 2005 Oct;68(4):933-41. Epub 2005 Jul 14. Review.

20.

The insulin-like growth factor-binding protein 1 gene is a primary target of peroxisome proliferator-activated receptors.

Degenhardt T, Matilainen M, Herzig KH, Dunlop TW, Carlberg C.

J Biol Chem. 2006 Dec 22;281(51):39607-19. Epub 2006 Oct 24.

Supplemental Content

Support Center